Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users

Neuroscience and Biobehavioral Reviews

Volumn 63, Issue , 2016, Pages 158-167

  Roberts, Carl Alexander ^a   Jones, Andrew ^a   Montgomery, Catharine ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Ecstasy; MDMA; Meta analysis; Molecular imaging; PET; Serotonin; SERT; SPECT

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; MIDOMAFETAMINE;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; BRAIN FUNCTION; CAUDATE NUCLEUS; DORSOLATERAL PREFRONTAL CORTEX; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; INSULA; LIMBIC CORTEX; MESENCEPHALON; MOLECULAR IMAGING; MULTIPLE DRUG ABUSE; NEOCORTEX; OCCIPITAL CORTEX; PARIETAL CORTEX; POSTERIOR CINGULATE; PRIORITY JOURNAL; PROTEIN BINDING; PUTAMEN; RAPHE NUCLEUS; REVIEW; TEMPORAL CORTEX; THALAMUS; ADULT; BRAIN; DIAGNOSTIC IMAGING; FEMALE; MALE; META ANALYSIS; METABOLISM; POSITRON EMISSION TOMOGRAPHY; YOUNG ADULT;

ADULT; BRAIN; FEMALE; HUMANS; MALE; MOLECULAR IMAGING; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 84958242670     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.02.003     Document Type: Review

References (43)

1. Adams K.H., Pinborg L.H., Svarer C., Hasselbalch S.G., Holm S., Haugbøl S., Madsen K., Frøkjær V., Martiny L., Paulson O.B., Knudsen G.M. A database of [18F]-altanserin binding to 5-HT2A receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage 2004, 21(3):1105-1113.
2. Buchert R., Thomasius R., Nebeling B., Petersen K., Obrocki J., Jenicke L., Wilke F., Wartberg L., Zapletalova P., Clausen M. Long-term effects of 'ecstasy' use on serotonin transporters of the brain investigated by PET. J. Nucl. Med. 2003, 44:375-384.
3. Buchert R., Thomasius R., Wilke F., Petersen K., Nebeling B., Obrocki J., Schulze M.S., Scmidt U., Clausen M. A voxel-based PET investigation of the long term effects of 'ecstasy' consumption on brain serotonin transporters. Am. J. Psychiatry 2004, 161:1181-1189.
4. Cole J.C. MDMA and the 'ecstasy paradigm'. J. Psychoact. Drugs 2014, 46(1):44-56.
5. de Win M.M.L., Jager G., Booij J., Reneman L., Schilt T., Lavini C., Olabarriaga S.D., Ramsey N.F., den Heeten G.J., van den Brink W. Neurotoxic effects of ecstasy on the thalamus. Br. J. Psychiatry 2008, 193:289-296.
6. de Win M.M.L., Reneman L., Reitsma J.B., den Heeten G.J., Booij J., van den Brink W. Mood disorders and serotonin transporter density in ecstasy users- the influence of long-term abstention, dose, and gender. Psychopharmacology 2004, 173:376-382.
7. Di Iorio C.R., Watkins T.J., Dietrich M.S., Aize C., Blackford J.U., Rogers B., Ansari M.S., Baldwin R.M., Li R., Kessler R.M., Salomon R.M., Benningfield M., Cowan R.L. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users. Arch. Gen. Psychiatry 2012, 69(4). 399-40.
8. Dumont G.J., Verkes R.J. A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. J. Psychopharmacol. 2006, 20:176-187.
9. European Monitoring Centre for Drugs, Drug Action European Drug Report, Trends and Developments 2015, Publications Office of the European Union, Luxembourg.
10. Fischer C., Hatzidimitriou G., Wlos J., Katz J., Ricaurte G. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-) 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). J. Neurosci. 1995, 15:5476-5485.
11. Frojaer V.G., Erritzoe D., Holst K.K., Madsen K.S., Fisher P.M., Madsen J., Svarer C., Knudsen G.M. In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users. Int. J. Neuropsychopharmacol. 2014, 17:1119-1128.
12. Gryglewski G., Lanzenberger R., Kranz G.S., Cumming P. Meta-analysis of molecular imaging of serotonin transporters in major depression. J. Cereb. Blood Flow Metab. 2014, 34:1096-1103.
13. Heinz A., Jones D.W. Serotonin transporters in ecstasy users. Br. J. Psychiatry 2000, 176:193-194. letter.
14. Higgins, J., Green, S. (ed.) (2011). Cochrane Handbook for Systematic Reviews of Interventions., The Cochrane Collaboration. Available from . http://www.cochrane-handbook.org.
15. Hornung J.P. The human raphe nuclei and the serotonergic system. J. Chem. Neuroanat. 2003, 26(4):331-343.
16. Hysek C.M., Simmler L.D., Ineichen M., Grouzmann E., Hoener M.C., Brenneisen R., Huwyler J., Liechti M.E. The Norepinepherine transporter inhibitor Reboxetine reduces stimulant effects of MDMA (ecstasy) in humans. Clin. Pharmacol. Ther. 2011, 90(2):246-255.
17. Hysek C.M., Simmler L.D., Nicola V.G., Vischer N., Donzelli M., Krähenbül S., Grouzmann E., Huwyler J., Hoener M.C., Liechti M.E. Duloxetine inhibits effects of MDMA ('ecstasy') In Vitro and in humans in a randomized placebo-controlled laboratory study. PLoS One 2012, 7(5):e36476.
18. Ioannidis J.P., Trikalonis T.A. An exploratory test for an excess of significant findings. Clin. Trials 2007, 4(3):245-253.
19. Kish S.J., Furukawa Y., Chang L.J., Tong J., Ginovart N., Wilson A., Houle S., Meyer J.H. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?. Nucl. Med. Biol. 2005, 32(2):123-128.
20. 11C]DASB and structural brain imaging study. BRAIN 2010, 133:1779-1797.
21. Kuikka J.T., Ahonen A.K. Toxic effect of MDMA on brain serotonin neurons. Lancet lett. 1999, 353:1269.
22. Light R.J., Pillemer D.B. Summing up. The Science of Reviewing Research 1984, University Press, Cambridge, MA, Harvard.
23. 1A receptor in alcohol dependence. Biol. Psychiatry 2009, 65(2):175-180.
24. McCann U.D., Szabo Z., Scheffel U., Dannals R.F., Ricaurte G.A. Positron emission tomographic evidence of toxic effect of MDMA (ecstasy) on brain serotonin neurons in human beings. Lancet 1998, 352:1433-1437.
25. 11C]DASB. Neuropsychopharmacology 2005, 30:1741-1750.
26. Molliver M.E., Berger U.V., Mamounas L.A., Molliver D.C., O'Hearn E., Wilson M.A. Neurotoxicity of MDMA and related compunds: anatomic studies. Ann. N. Y. Acad. Sci. 1990, 600:640-661.
27. Montgomery C., Fisk J.E., Newcombe R., Murphy P.N. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory. Psychopharmacology 2005, 182:262-276.
28. Parsey R.V., Kegeles L.S., Hwang D.-R., Simpson N., Abi-Dargham A., Mawlawi O., Slifstein M., Van Heertum R.L., Mann J.J., Laruelle M. In Vivo quantification of brain serotonin transporters in humans using [11C]McN-5652. J. Nucl. Med. 2000, 41:1465-1477.
29. Parsey R.V., Kent J.M., Oquendo M.A., Richards M.C., Pratap M., Cooper T.B., Arango V., Mann J.J. Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography. Biol. Psychiatry 2006, 59:821-828.
30. Reneman L., Booij J., de Bruin K., Reitsma J.B., de Wolffe F.A., Gunning W.B., den Heeten G.J., van den Brink W. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 2001, 358:1864-1869.
31. Reneman L., Lavalaye J., Schmand B., de Wolff F., van den Brink W., den Heeten G.J., Booij J. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy'). Arch. Gen. Psychiatry 2001, 58:901-906.
32. 2A receptors in rat and human brain. Neuropsychopharmacology 2002, 26:387-396.
33. Reneman L., Booij J., Schmand B., van den Brink W., Gunning B. Memory disturbances in 'Ecstasy' users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 2000, 148:322-324.
34. Ricaurte G.A., McCann U.D. Experimental studies on 3,4-methylenedioxymethamphetamine (MDMA, 'ECSTASY') and its potential to damage brain serotonin neurons. Neurotoxic. Res. 2001, 3:85-99.
35. Ricaurte G.A., DeLanney L.E., Irwin I., Langston J.W. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res. 1988, 446(1):165-168.
36. Roberts C.A., Montgomery C. fNIRS suggests increased effort during executive access in ecstasy polydrug users. Psychopharmacology 2015, 232:1571-1582.
37. Rohatgi, A. (2015). Web Plot Digitalizer: HTML5 based online tool to extract numerical data from plot images. Version 3. [WWW document] URL (accessed June 2015). http://arohatgi.info/WebPlotDigitizer/app/.
38. Scheffel U., Szabo Z., Mathews W.B., Finley P.A., Dannals R.F., Ravert H.T., Szabo K., Yuan J., Ricaurte G.A. In vivo detection of short - and long term MDMA neurotoxicity - A positron emission tomography study in the living baboon brain. Synapse 1998, 29(183-192).
39. Selvaraj S., Hoshi R., Bhagwagar Z., Murthy N.V., Hinz R., Cowen P., Curran H.V., Grasby P. Brain serotonin transporter binding in former users of MDMA ('ecstasy'). Br. J. Psychiatry 2009, 194:355-359.
40. Stern J.A.C., Harbord R.M. Funnel plots in meta-analysis. Stata J. 2004, 4(2):127-141.
41. Thomasius R., Petersen K., Bucherts R., Andresen B., Zapletalova P., Wartberg L., Nebeling B., Schmoldt A. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 2003, 167:85-96.
42. 11C]MDL 100907. Neuropsychopharmacology 2012, 37:1465-1473.
43. Verrico D.D., Miller G.M., Madras B.K. MDMA (Ecstasy) and human dopamine, norepinepherine and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology 2007, 189(4):489-503.